tirzepatide and pristiq A patient with a pituitary disorder starting cabergoline, desvenlafaxine ( Pristiq), guanfacine hydrochloride (Guanfacine) – are there any serious drug interactions to be concerned about? Tirzepatide – 5mg – Prime

doi:10.1007/s40268-013-0005-9 Liu L, Shi H, Xie M, Sun Y, Nahata MC

Reports of dizziness have also appeared in these databases, although not in high numbers

How quickly you escalate also matters

This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications

After taking medication for a while, a maintenance dose is prescribed to support ongoing weight loss and help reach and maintain a healthy body weight